Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chinook Therapeutics
Biotech
Novartis' $3.2B Chinook bet takes flight as phase 3 hits goal
The kidney disease data position the Swiss drugmaker to apply for accelerated approval from the FDA next year.
Nick Paul Taylor
Oct 30, 2023 8:16am
Novartis inks $3.2B Chinook buyout to lift kidney disease plans
Jun 12, 2023 4:50am
Chinook grounds phase 1 kidney drug trial over adverse event
Apr 11, 2023 10:40am
Sanofi's John Reed jumps ship for J&J—Chutes & Ladders
Feb 17, 2023 9:30am
Chinook launches a new biotech with major VCs in China
Nov 30, 2021 8:00am
Kidney-focused Chinook to bank $106M ahead of Aduro merger close
Aug 18, 2020 10:35am